Answers are grounded in this paper and cite their sources.
Explores enantioselective catalysis using chiral nanotubes, suggesting efficient substrate adsorption.
The precise synthesis of chiral helical nanotubes and the fundamental understanding of how they dictate catalytic enantioselectivity represent pivotal challenges in the field of enantioselective catalysis. Herein, we report a template-assisted strategy for constructing right- and left-handed polyaniline (P- and M-PANI) helical nanotubes. This platform enables the straightforward engineering of chiral nanozymes through the integration of palladium (Pd) nanocubes (Pdc) and Pd nanoicosahedrons (Pdi). The resulting P-PANI-Pdc/Pdi and M-PANI-Pdc/Pdi exhibit catalytic enantioselectivity that is dually dependent on both the supramolecular chirality of PANI helical nanotubes and the crystal facet of Pd-based nanoparticles. Accordingly, P-PANI-Pdc/Pdi nanozymes preferentially oxidize 3,4-dihydroxy-S-phenylalanine (S-DOPA) with selectivity factors of 2.54 and 2.24. In contrast, their M-PANI counterparts favor R-DOPA, showing selectivity factors of 2.68 and 2.30. Mechanistic studies revealed that this enantioselectivity stems from more efficient adsorption of the preferred substrate. Furthermore, we show that the enantioselectivity difference originating from Pdc and Pdi is directly attributable to their crystal facet-dependent adsorption behaviors. This work establishes an effective route to chiral nanotubes and provides a fundamental link between the nanoscale surface structure and macroscopic chiral performance.
No takes yet. Share an insight, caveat, or question.
Khamis et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: